1) Mouli, V.P., Ananthakrishnan, A.N. Review article: Vitamin D and inflammatory bowel diseases (2014) Alimentary Pharmacology and Therapeutics, 39 (2), pp. 125-136.

2) Salcedo, R., Cataisson, C., Hasan, U., Yuspa, S.H., Trinchieri, G. MyD88 and its divergent toll in carcinogenesis (2013) Trends in Immunology, 34 (8), pp. 379-389.

3) Zindl, C.L., Lai, J.-F., Lee, Y.K., Maynard, C.L., Harbour, S.N., Ouyang, W., Chaplin, D.D., Weaver, C.T. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis (2013) Proceedings of the National Academy of Sciences of the United States of America, 110 (31), pp. 12768-12773.

4) Tanaka, T., Ishikawa, H. Mast cells and inflammation-associated colorectal carcinogenesis (2013) Seminars in Immunopathology, 35 (2), pp. 245-254.

5) Tanaka, T. Development of an inflammation-associated colorectal cancer model and its application for research on carcinogenesis and chemoprevention (2012) International Journal of Inflammation, 2012, art. no. 658786.

5) Sussman, D.A., Santaolalla, R., Strobel, S., Dheer, R., Abreu, M.T. Cancer in inflammatory bowel disease: Lessons from animal models (2012) Current Opinion in Gastroenterology, 28 (4), pp. 327-333.

6) Per??e, M., Cerar, A. Dextran sodium sulphate colitis mouse model: Traps and tricks (2012) Journal of Biomedicine and Biotechnology, 2012, art. no. 718617.

7) Vora, P., McGovern, D.P.B. LRRK2 as a negative regulator of NFAT: Implications for the pathogenesis of inflammatory bowel disease (2012) Expert Review of Clinical Immunology, 8 (3), pp. 227-229.

8) Zhao, W.-C., Song, L.-J., Deng, H.-Z. Protective effect of total alkaloids of sophora alopecuroides on dextran sulfate sodium-induced chronic colitis (2011) Chinese Journal of Integrative Medicine, 17 (8), pp. 616-624.

9) Azuma, Y.-T., Nakajima, H., Takeuchi, T. IL-19 as a potential therapeutic in autoimmune and inflammatory diseases (2011) Current Pharmaceutical Design, 17 (34), pp. 3776-3780.

10) Naito, Y., Takagi, T., Uchiyama, K., Yoshikawa, T. Heme oxygenase-1: A novel therapeutic target for gastrointestinal diseases (2011) Journal of Clinical Biochemistry and Nutrition, 48 (2), pp. 126-133.

11) Egea, L., Hirata, Y., Kagnoff, M.F. GM-CSF: A role in immune and inflammatory reactions in the intestine (2010) Expert Review of Gastroenterology and Hepatology, 4 (6), pp. 723-731.

12) Takagi, T., Naito, Y., Uchiyama, K., Yoshikawa, T. The role of heme oxygenase and carbon monoxide in inflammatory bowel disease (2010) Redox Report, 15 (5), pp. 193-201.

13) Shukla, P., Gupta, G., Singodia, D., Shukla, R., Verma, A.K., Dwivedi, P., Kansal, S., Mishra, P.R. Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactives (2010) Expert Opinion on Drug Delivery, 7 (9), pp. 993-1011.

14) Solomon, L., Mansor, S., Mallon, P., Donnelly, E., Hoper, M., Loughrey, M., Kirk, S., Gardiner, K. The dextran sulphate sodium (DSS) model of colitis: An overview (2010) Comparative Clinical Pathology, 19 (3), pp. 235-239.

15) Strauch, U.G., Grunwald, N., Obermeier, F., G??rster, S., Rath, H.C. Loss of CD103+ intestinal dendritic cells during colonic inflammation (2010) World Journal of Gastroenterology, 16 (1), pp. 21-29.

16) Maxwell, J.R., Brown, W.A., Smith, C.L., Byrne, F.R., Viney, J.L. Methods of inducing inflammatory bowel disease in mice (2009) Current Protocols in Pharmacology, (SUPPL.47), pp. 5.58.1-5.58.37.

17) Waldner, M.J., Neurath, M.F. Chemically induced mouse models of colitis (2009) Current Protocols in Pharmacology, (SUPPL. 46), pp. 5.55.1-5.55.15.

18) Nishihira, J., Mitsuyama, K. Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel disease (2009) Current Pharmaceutical Design, 15 (18), pp. 2104-2109.

19) Soeda, S., Sakata, A., Ochiai, T., Yasuda, K., Kuramoto, Y., Shimeno, H., Toda, A., Eyanagi, R., Hikishima, S., Yokomastu, T., Shibuya, S. Sphingomyelinase inhibition suggests a possible new strategy for the treatment of inflammatory bowel disease (2008) Current Drug Therapy, 3 (3), pp. 218-225.

20) Kawada, M., Arihiro, A., Mizoguchi, E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease (2007) World Journal of Gastroenterology, 13 (42), pp. 5581-5593.

21) Clapper, M.L., Cooper, H.S., Chang, W.-C.L. Dextran sulfate sodium-induced colitis-associated neoplasia: A promising model for the development of chemopreventive interventions (2007) Acta Pharmacologica Sinica, 28 (9), pp. 1450-1459.

22) Butterworth, J.R. Another important function for an old friend! The role of iron in colorectal carcinogenesis (2006) Gut, 55 (10), pp. 1384-1386.

23) Di Pace, R.F., Massa, S., Ribeiro, O.G., Cabrera, W.H.K., De Franco, M., Starobinas, N., Seman, M., Iba?±ez, O.C.M. Inverse genetic predisposition to colon versus lung carcinogenesis in mouse lines selected based on acute inflammatory responsiveness (2006) Carcinogenesis, 27 (8), pp. 1517-1525.

24) Guarner, F. Inulin and oligofructose: Impact on intestinal diseases and disorders (2005) British Journal of Nutrition, 93 (SUPP), pp. S61-S65.

25) Dagenais, S., Haldeman, S., Wooley, J.R. Intraligamentous injection of sclerosing solutions (prolotherapy) for spinal pain: A critical review of the literature (2005) Spine Journal, 5 (3), pp. 310-328. Cited 30 times.

26) Mirvish, S.S., Haorah, J., Zhou, L., Hartman, M., Morris, C.R., Clapper, M.L. N-Nitroso compounds in the gastrointestinal tract of rats and in the feces of mice with induced colitis or fed hot dogs or beef (2003) Carcinogenesis, 24 (3), pp. 595-603.